Lianpan Dai

机构：Chinese Academy of Sciences, Czech Academy of Sciences, Institute of Microbiology, Institute of Microbiology · ORCID：0000-0001-8352-1327

发表论文 83 篇 · 总被引 5151 次 · h-index 27

代表论文

• Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses (2024 · ACS Nano · 被引 38)
• Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2 (2023 · Proceedings of the National Academy of Sciences · 被引 36)
• Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies (2024 · Med · 被引 24)
• Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (2023 · Signal Transduction and Targeted Therapy · 被引 22)
• Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses (2024 · Cell Reports · 被引 21)
• Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera (2024 · npj Vaccines · 被引 20)